We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Implementation of Pharmacogenetics to Individualize Treatment Regimens for Children with Acute Lymphoblastic Leukemia.
- Authors
Maamari, Dimitri; El-Khoury, Habib; Saifi, Omran; Muwakkit, Samar A; Zgheib, Nathalie K
- Abstract
Despite major advances in the management and high cure rates of childhood acute lymphoblastic leukemia (ALL), patients still suffer from many drug-induced toxicities, sometimes necessitating dose reduction, or halting of cytotoxic drugs with a secondary risk of disease relapse. In addition, investigators have noted significant inter-individual variability in drug toxicities and disease outcomes, hence the role of pharmacogenetics (PGx) in elucidating genetic polymorphisms in candidate genes for the optimization of disease management. In this review, we present the PGx data in association with main toxicities seen in children treated for ALL in addition to efficacy, with a focus on the most plausible germline PGx variants. We then follow with a summary of the highest evidence drug-gene annotations with suggestions to move forward in implementing preemptive PGx for the individualization of treatment regimens for children with ALL.
- Subjects
LYMPHOBLASTIC leukemia; ACUTE leukemia; PHARMACOGENOMICS; INDUSTRIAL efficiency; DISEASE relapse; GENETIC polymorphisms
- Publication
Pharmacogenomics & Personalized Medicine, 2020, Vol 13, p295
- ISSN
1178-7066
- Publication type
Article
- DOI
10.2147/PGPM.S239602